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Summary 20 
Methicillin-resistant Staphylococcus aureus (MRSA) transmission in hospital wards is 21 
associated with adverse outcomes for patients and increased costs for hospitals. 22 
The transmission process is inherently stochastic and the randomness emphasised 23 
by the small population sizes involved. As such, a stochastic model was proposed to 24 
describe the MRSA transmission process, taking into account the related 25 
contribution and modelling of the associated microbiological environmental 26 
contamination. The model was used to evaluate the performance of five common 27 
interventions and their combinations on six potential outcome measures of interest 28 
under two hypothetical disease burden settings. The model showed that the optimal 29 
intervention combination varied depending on the outcome measure and burden 30 
setting. In particular, it was found that certain outcomes only required a small subset 31 
of targeted interventions to control the outcome measure, while other outcomes still 32 
reported reduction in the outcome distribution with up to all five interventions 33 
included. This study described a new stochastic model for MRSA transmission within 34 
a ward and highlighted the use of the generalised Mann-Whitney statistic to compare 35 
the distribution of the outcome measures under different intervention combinations to 36 
assist in planning future interventions in hospital wards under different potential 37 
outcome measures and disease burden. 38 
  39 
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INTRODUCTION 40 
Healthcare associated infections (HAIs) are adverse events that can arise during 41 
hospitalisation. Multidrug-resistant organisms (MDROs), for example 42 
methicillin-resistant Staphylococcus aureus (MRSA), are common causes of these 43 
HAIs with patients typically becoming colonized with the organism prior to developing 44 
an infection. Treatment options for MDROs are becoming increasingly limited due to 45 
the relative scarcity in development of new treatments compared with the rate of 46 
resistance acquisition [1]. As such, the role of routine infection control and prevention 47 
(ICP) practices are of great importance in reducing the occurrence of HAIs. 48 
Intervention studies which typically investigate the effects of one or a combination of 49 
interventions in reducing HAIs provide a good first line of evidence for particular 50 
interventions to be incorporated into routine ICP practices. These studies also assist 51 
in building mathematical model representations of the healthcare setting. Such 52 
models then allow for further probing of the effects of the interventions which may 53 
not have been feasible or potentially ethical to investigate in a clinical setting but 54 
could prove useful in assisting decision-making, particularly when hospital resources 55 
are severely limited. The model findings could also provide recommendations for 56 
future intervention studies.  57 
Susceptible patients are typically modelled to be colonized (a state which precedes 58 
an infection) through a forcing term (referred to as the force of infection) which is a 59 
function of the number of colonized patients currently present in the ward as well as 60 
the colonized hospital staff in the ward at the time and also contact frequency. As 61 
hospital staff are not routinely screened for pathogen colonization [2], obtaining high 62 
quality data on hospital staff has proven difficult. 63 
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That said, the vast majority of mathematical models consider vector based cross-64 
transmission between patients and transiently contaminated healthcare workers 65 
(HCWs) to be the dominant transmission mechanism for MDROs such as MRSA [3]. 66 
Only a small number of papers have considered alternative transmission routes 67 
typically by incorporating a constant source (such as in Forrester et al. [4]). Even 68 
fewer have explicitly modelled environmental contamination as an alternative 69 
transmission route [5, 6, 7, 8, 9, 10]. However, such models only calibrated the 70 
parameter estimates related to the environmental contamination to match observed 71 
patient incidence rather than using environmental contamination data. 72 
This paper presents a stochastic model for ward MDRO transmission based on 73 
patient dynamics, as patient data are typically more readily available compared with 74 
hospital staff, coupled with a time series model of environmental contamination 75 
which was parametrised by environmental contamination data. Due to the low 76 
reported prevalence of HCW carriage [11], the small proportion of nosocomial 77 
outbreaks attributable to HCWs [2] and the few adverse outcomes reported for 78 
HCWs [11], we assumed that transmission is implicitly facilitated by HCWs, who are 79 
temporarily contaminated with MRSA through contact with an MRSA-positive patient 80 
or environmental contamination, due to the limited mobility of patients, as is also 81 
common practice in similar modelling studies [4, 10, 12, 13]. Inclusion of HCWs 82 
typically involves substantial simplification of realistic HCW dynamics [8, 14] or 83 
substantial additional data collection to account for the heterogeneity between HCWs 84 
[15,16,17,18,19] beyond the scope of this study.  85 
The model was run under two settings; the first is based on MRSA dynamics in a 86 
developed country (UK and Switzerland study estimates were used here) where 87 
MRSA data and parameters are more easily readily sourced, and the second is for a 88 
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hypothetical scenario where the pathogen is more readily transmitted and not as 89 
easy to detect. The second setting could be representative of a novel pathogen in 90 
the healthcare setting, a new strain of MRSA that is more virulent than existing 91 
strains or perhaps reflective of a resource-poor setting such as in low-income 92 
countries [13] where such modelling studies could be a great benefit. The impact of 93 
five common healthcare interventions [3] and their various combinations were 94 
investigated for six potential outcome measures under both settings separately. 95 
Limitations and future directions in model development are provided in the 96 
Discussion. 97 
METHODS 98 
Model formulation 99 
The model proposed is for a single ward setting and comprises of: (i) a ward-level 100 
patient arrival process; (ii) an individual-based model for patient transitions in the 101 
ward; and (iii) a time series model for the level of environmental contamination. 102 
At any time 𝑡𝑡, patients in the ward are categorized based on their MRSA status 103 
where they can be in the susceptible group (𝑆𝑆(𝑡𝑡)), the undetected MRSA colonized 104 
group (𝐶𝐶𝑥𝑥𝑥𝑥(𝑡𝑡)), the detected with MRSA colonization and undergoing appropriate 105 
treatment group (𝐶𝐶𝑥𝑥(𝑡𝑡)), the undetected MRSA infected group (𝐼𝐼𝑥𝑥𝑥𝑥(𝑡𝑡)), or the 106 
detected with MRSA infection and undergoing appropriate treatment group (𝐼𝐼𝑥𝑥(𝑡𝑡)). A 107 
schematic illustration of the model is provided in Figure 1 with 𝐸𝐸(𝑡𝑡) representing the 108 
ward environmental contamination levels.  109 
The model is an example of Discrete Event Simulation (DES), a technique that is 110 
widely used in health care research [20, 21, 22]. While perhaps more commonly 111 
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used in scheduling problems, DES has also been applied to investigate pathogen 112 
transmission [21]. DES provides a flexible modelling approach to represent individual 113 
patient transitions during their hospitalisation episode, allowing for the inclusion of 114 
stochastic variability (important for small population studies such as in a hospital 115 
ward) and effects of individual patient information.  116 
Patient admissions into the ward are modelled as a right-censored (at ward capacity 117 
M) Poisson process (𝐴𝐴(𝑡𝑡)~ 𝑃𝑃𝑃𝑃(𝜆𝜆)) with a Binomial variable to separate arrivals to 118 
either susceptibles (𝐴𝐴𝑆𝑆(𝑡𝑡)) or colonized (but not detected, i.e.𝐶𝐶𝑥𝑥𝑥𝑥) (𝐴𝐴𝐶𝐶(𝑡𝑡)). It is 119 
assumed that patients cannot be infected on admission (as infected patients are 120 
typically isolated or cohorted to reduce transmission risk to other patients). Excess 121 
arrivals, beyond the ward capacity 𝑀𝑀, are assumed to be allocated to a separate 122 
ward thus creating the right censoring in the arrival process. 123 
The likelihood for the admissions at time 𝑡𝑡 can therefore be written as: 124 
𝑃𝑃(𝐴𝐴(𝑡𝑡) = 𝑖𝑖,𝐴𝐴𝑆𝑆(𝑡𝑡) = 𝑗𝑗,𝐴𝐴𝐶𝐶(𝑡𝑡) = 𝑖𝑖 − 𝑗𝑗 |𝑌𝑌(𝑡𝑡 − 1))
=  
⎩
⎪
⎨
⎪
⎧
𝜆𝜆𝑖𝑖
𝑖𝑖! exp {−𝜆𝜆} �𝑖𝑖𝑗𝑗� 𝜗𝜗𝑗𝑗(1 − 𝜗𝜗)𝑖𝑖−𝑗𝑗 0 ≤ 𝑖𝑖 < 𝑌𝑌(𝑡𝑡 − 1)
�
𝜆𝜆𝑙𝑙
𝑙𝑙! exp {−𝜆𝜆} �𝑙𝑙𝑗𝑗� 𝜗𝜗𝑗𝑗(1 − 𝜗𝜗)𝑙𝑙−𝑗𝑗∞
𝑙𝑙=𝑌𝑌(𝑡𝑡−1) 𝑖𝑖 = 𝑌𝑌(𝑡𝑡 − 1)  
where 𝑌𝑌(𝑡𝑡) is the number of empty beds in the ward at time 𝑡𝑡 and 𝜗𝜗 is the 125 
proportion of admissions that arrive susceptible. 126 
The admissions at time 𝑡𝑡 will then be assigned to the empty beds in the ward but will 127 
not undergo the individual patient transitions until the next time point. 128 
The individual-based model, which is for patient transitions in the ward, processes 129 
each patient present in the ward at each time point based on the patient’s current 130 
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MRSA status. The following assumptions were used to formulate the individual-131 
based model patient transitions: 132 
1. each patient can only undergo one transition (discharge, colonization, 133 
infection, recovery, detection) per time period 134 
2. susceptible patients have to be colonized before developing an infection 135 
3. patient colonization will always be undetected when first colonized 136 
4. colonized patients will not return to the susceptible state 137 
5. undetected colonized patients cannot transition directly to the detected 138 
infected state as it counts as two transitions (detection and infection) 139 
6. detected colonized and infected patients cannot return to the undetected state 140 
7. detected colonized patients are placed under the decolonisation treatment 141 
and cannot develop an infection 142 
8. infected patients only recover to the colonized state, and not to the 143 
susceptible state 144 
9. detected infected patients are placed under an appropriate treatment which 145 
increases their probability of recovery over their infection duration 146 
10. undetected infected patients cannot recover as they have not received 147 
appropriate treatment yet 148 
At each time point 𝑡𝑡, each susceptible patient 𝑆𝑆 can either leave the ward as 149 
susceptible with probability 𝑝𝑝𝐿𝐿, become colonized (but not detected) with probability 150 
𝑝𝑝𝐶𝐶, or remain susceptible with probability 𝑝𝑝𝑠𝑠  such that 𝑝𝑝𝐿𝐿 + 𝑝𝑝𝐶𝐶  +  𝑝𝑝𝑠𝑠 =  1. 151 
The probability of being colonized is modelled as 𝑝𝑝𝐶𝐶 = 𝑓𝑓𝐸𝐸(1 − 𝑝𝑝𝐿𝐿) w here 𝑓𝑓𝐸𝐸  is an 152 
increasing function of 𝐸𝐸(𝑡𝑡),𝐶𝐶𝑥𝑥𝑥𝑥(𝑡𝑡 − 1),𝐶𝐶𝑥𝑥(𝑡𝑡 − 1), 𝐼𝐼𝑥𝑥𝑥𝑥(𝑡𝑡 − 1) and 𝐼𝐼𝑥𝑥(𝑡𝑡 − 1). Specifically, 153 
the following form for 𝑓𝑓𝐸𝐸  was used 154 
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𝑓𝑓𝐸𝐸(𝑡𝑡) = 1 − exp {−𝜈𝜈(𝑡𝑡)Δ𝑡𝑡}  
where 𝜈𝜈(𝑡𝑡) =  𝛽𝛽0 + 𝛽𝛽1𝐶𝐶𝑥𝑥𝑥𝑥(𝑡𝑡 − 1) +  𝛽𝛽2𝐶𝐶𝑥𝑥(𝑡𝑡 − 1) +  𝛽𝛽3𝐼𝐼𝑥𝑥𝑥𝑥(𝑡𝑡 − 1) +  𝛽𝛽4𝐼𝐼𝑥𝑥(𝑡𝑡 − 1) +  𝛽𝛽5𝐸𝐸(𝑡𝑡) 155 
is the instantaneous hazard of being colonized, or also known as the force of 156 
infection for this model, and 0 ≤ 𝑓𝑓𝐸𝐸(𝑡𝑡) < 1 ∀ 𝑡𝑡. Lastly, 𝑝𝑝𝑆𝑆 = (1 − 𝑓𝑓𝐸𝐸)(1 − 𝑝𝑝𝐿𝐿). 157 
Each undetected colonized patient 𝐶𝐶𝑥𝑥𝑥𝑥  is detected with probability 𝜌𝜌 (assumed to be 158 
the screening test sensitivity). Otherwise, the undetected colonized patient can either 159 
leave the ward with probability 𝑞𝑞𝐿𝐿, develop an infection with probability 𝑞𝑞𝐼𝐼 , or remain 160 
colonized in the ward with probability 𝑞𝑞𝐶𝐶  such that 𝑞𝑞𝐿𝐿 + 𝑞𝑞𝐼𝐼 + 𝑞𝑞𝐶𝐶 = 1. No additional 161 
structure is imposed on these probabilities values as it is assumed that each 162 
colonized patients will have the same probability values. 163 
Each detected colonized patient 𝐶𝐶𝑥𝑥  can either leave the ward with probability 𝑞𝑞𝐿𝐿 or 164 
remain colonized and detected with probability 1 − 𝑞𝑞𝐿𝐿. Due to a lack of information to 165 
differentiate the probability of leaving for undetected and detected colonized patients, 166 
these were assumed to be same. One of the interventions considered (DECOL) 167 
increases the probability of leaving for just the detected colonized patients. 168 
Each undetected infected patient 𝐼𝐼𝑥𝑥𝑥𝑥  can either be detected with probability 𝜌𝜌 or 169 
remain undetected with probability 1 −  𝜌𝜌. 170 
Each detected infected patient 𝐼𝐼𝑥𝑥  will have a probability 𝑟𝑟𝐶𝐶 of recovering (transitioning 171 
to 𝐶𝐶𝑥𝑥) where 172 
𝑟𝑟𝐶𝐶(𝑡𝑡|𝜓𝜓, 𝑡𝑡𝑖𝑖𝑘𝑘) =  1 − exp {−𝜓𝜓(𝑡𝑡 − 𝑡𝑡𝑖𝑖𝑘𝑘)} 
is an increasing function of the difference of the current time (𝑡𝑡) and the time the 173 
individual 𝑘𝑘 became infected (𝑡𝑡𝑖𝑖𝑘𝑘). In other words, it is assumed that the longer a 174 
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patient is infected, the more likely the patient will recover at the next time point. An 175 
infected patient remains infected with probability 1 − 𝑟𝑟𝐶𝐶. 176 
By definition, only the (approximate) date that a patient is detected to be colonized or 177 
infected is available from hospital surveillance databases. The transition times from 178 
susceptible to undetected with MRSA colonization (𝑡𝑡𝑐𝑐𝑘𝑘), and subsequently 179 
undetected infection (𝑡𝑡𝑖𝑖𝑘𝑘) are typically imputed from a range of plausible values 180 
between the patient’s admission date (𝑎𝑎𝑘𝑘) and first positive screening test date (𝑑𝑑𝑘𝑘) 181 
where the full conditional for (𝑡𝑡𝑐𝑐𝑘𝑘, 𝑡𝑡𝑖𝑖𝑘𝑘) can be written as 182 
(1 − 𝜌𝜌)𝑁𝑁𝐹𝐹(𝑡𝑡𝑖𝑖𝑘𝑘)𝑒𝑒𝑒𝑒𝑝𝑝 � log 𝜈𝜈(𝑡𝑡𝑏𝑏) −  �𝑆𝑆(𝑡𝑡𝑥𝑥)𝜈𝜈(𝑡𝑡𝑥𝑥)(𝑡𝑡𝑥𝑥+1 − 𝑡𝑡𝑥𝑥)
𝑥𝑥𝑏𝑏
� 𝑞𝑞𝐼𝐼𝑒𝑒𝑒𝑒𝑝𝑝{− 𝑞𝑞𝐼𝐼(𝑡𝑡𝑖𝑖𝑘𝑘 − 𝑡𝑡𝑐𝑐𝑘𝑘)} 
where 𝑡𝑡𝑐𝑐𝑘𝑘 < 𝑡𝑡𝑖𝑖𝑘𝑘, 𝑁𝑁𝐹𝐹(𝑡𝑡𝑖𝑖𝑘𝑘) is the number of false negative screening test results for 183 
patient 𝑘𝑘 given 𝑡𝑡𝑖𝑖𝑘𝑘, the 𝑏𝑏 subscript indexes time points where a susceptible patient 184 
becomes colonised between 𝑡𝑡𝑐𝑐𝑘𝑘 to patient 𝑘𝑘’s discharge and the 𝑑𝑑 subscript indexes 185 
the time points where 𝑣𝑣(𝑡𝑡) changes between 𝑎𝑎𝑘𝑘 and 𝑡𝑡𝑐𝑐𝑘𝑘. The expression can be 186 
evaluated for all potential (𝑡𝑡𝑐𝑐𝑘𝑘, 𝑡𝑡𝑖𝑖𝑘𝑘) values to obtain a discrete distribution to be used 187 
in a Metropolis-Hastings step within a Markov chain Monte Carlo algorithm to impute 188 
these unobserved quantities and estimate the remaining model parameters  [4, 14, 189 
23]. 190 
An autoregressive-moving average time series model with exogenous covariates 191 
(ARMAX) [24] is used to describe the environmental contamination levels 𝐸𝐸(𝑡𝑡). The 192 
exogenous covariates assumed to be contributing to the levels of environmental 193 
contamination at time 𝑡𝑡 are the 𝐶𝐶𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥𝑥𝑥 patients in the ward at time 𝑡𝑡 −  1. It is 194 
assumed that detected (colonized and infected) MRSA patients undergo the 195 
decolonization treatment which halts shedding from the patient to the environment. 196 
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The orders of the ARMAX model are determined using the auto.arima() function 197 
in the R package forecast [25]. 198 
Parameter values 199 
The model parameter values used for the normal burden setting simulations are 200 
summarized in Table 1. Additional details of the parametrisation are provided in the 201 
supplementary material. The normal burden setting is reflective of MRSA burden in a 202 
typical hospital ward in a developed country. These parameters values are also used 203 
in the high burden setting simulations with the following modifications: 204 
1. there is an additional factor of two multiplying 𝜈𝜈(𝑡𝑡) 205 
2. the probability of a colonized patient developing an infection 𝑞𝑞𝐼𝐼 is doubled and 206 
𝑞𝑞𝐶𝐶 is reduced accordingly to ensure  𝑞𝑞𝐿𝐿 + 𝑞𝑞𝐼𝐼 + 𝑞𝑞𝑐𝑐 = 1 207 
3. there is decreased sensitivity in the screening test, 𝜌𝜌 = 0.6 208 
i.e. we assumed that in this setting, the hypothetical pathogen is more likely to 209 
colonize susceptible patients, colonized patients more readily develop an infection 210 
and it is harder to detect the presence of the pathogen. The high burden setting 211 
attempts to mimic either the MRSA dynamics in a developing country [26] or a novel 212 
strain of pathogen that is more virulent and less readily detected by routine 213 
surveillance.  214 
There was no available source to estimate the parameter 𝜔𝜔 which represents the 215 
difference between colonized and infected patients on the force of infection. The 𝜔𝜔 216 
value in the Results section was 1 as a reflection of the lack of information on the 217 
parameter. Alternative values of 0.1 and 1.9 were also investigated in the parameter 218 
sensitivity analysis (provided in the supplementary material). We found that the AR, 219 
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𝐶𝐶𝑥𝑥𝑥𝑥  and 𝐶𝐶𝑥𝑥  outcomes (defined below) were particularly sensitive to a low value of 𝜔𝜔 220 
(giving a stronger influence to colonized patients) in both normal and high burden 221 
settings. Distributions of AR outcome for the different values of 𝜔𝜔 are provided in 222 
Figure 2. Similar plots for the other outcomes and parameters are provided in the 223 
supplementary material. 224 
Interventions 225 
Five common intervention strategies were considered in the model investigation 226 
below: 227 
1. no colonized on admission (COA) (. 𝜗𝜗 = 1) where all patients who are 228 
colonized on admission are assumed to be detected on admission and 229 
isolated elsewhere, i.e. universal screening [27] 230 
2. improved environmental cleaning (ENV) which halved the intercept term in the 231 
environmental time series model (𝛼𝛼1) [28].  232 
3. improved contact precaution practices (CP) which decreases 𝜈𝜈 by a factor of 𝜉𝜉 233 
where 𝜉𝜉 was set to 0.75 [29]. 234 
4. perfect screening test sensitivity (SENS) where test sensitivity 𝜌𝜌 was set to 235 
1[14]. 236 
5. improved decolonization treatment for colonized patients (DECOL) where the 237 
probability for a 𝐶𝐶𝑥𝑥 patient leaving the ward is now 𝑞𝑞𝐿𝐿 + Δ (with the probability 238 
of staying adjusted accordingly) [14]. 239 
We considered six outcome measures for the investigations. They are the attack rate 240 
(AR) defined as the average of the force of infection 𝜈𝜈(𝑡𝑡) [14] as well as the 241 
cumulative numbers of 242 
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• patients who were colonized on admission (AC), 243 
• patients who were colonized but not detected (𝐶𝐶𝑥𝑥𝑥𝑥) 244 
• detected, colonized patients (𝐶𝐶𝑥𝑥) 245 
• patients who were infected but not detected (𝐼𝐼𝑥𝑥𝑥𝑥), and 246 
• detected, infected patients (𝐼𝐼𝑥𝑥). 247 
Note that there is a slight abuse of notation where 𝐶𝐶𝑥𝑥𝑥𝑥,𝐶𝐶𝑥𝑥, 𝐼𝐼𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥  refer to the 248 
cumulative number of patients in each group for the outcome measures, but the 249 
time-varying prevalence of the groups in the model. 250 
Due to the stochastic model formulation, each intervention setting was simulated 251 
1000 times and we compared the distributional differences of the outcomes rather 252 
than just point estimates of the outcomes.  253 
Pairs of distributions (denoted generally by 𝑋𝑋 and 𝑌𝑌 here) were assessed using the 254 
generalized Mann-Whitney statistic which estimates the parameter 𝜃𝜃 = 𝑃𝑃(𝑌𝑌 > 𝑋𝑋) +255  1
2
 𝑃𝑃(𝑌𝑌 = 𝑋𝑋) using 𝜃𝜃� =  𝑈𝑈
𝑚𝑚𝑚𝑚
 where 𝑈𝑈 =  ∑ ∑ 𝟙𝟙𝑚𝑚𝑗𝑗=1 �𝑌𝑌𝑗𝑗 > 𝑋𝑋𝑖𝑖� + 12𝑚𝑚𝑖𝑖=1  𝟙𝟙(𝑌𝑌𝑗𝑗 = 𝑋𝑋𝑖𝑖) with 256 
{𝑌𝑌𝑗𝑗;  𝑗𝑗 =  1, . . . ,𝑛𝑛}  and {𝑋𝑋𝑖𝑖;  𝑖𝑖 =  1, . . . ,𝑚𝑚} being samples from the 𝑌𝑌 and 𝑋𝑋 distributions 257 
respectively. Confidence intervals for 𝜃𝜃� were computed based on Method 5 of 258 
Newcombe [30]. 259 
Following the definition above, values of 𝜃𝜃 larger than 0.5 indicate that the 𝑌𝑌 is 260 
stochastically larger than 𝑋𝑋 and, conversely, values of 𝜃𝜃 less than 0.5 indicate 𝑋𝑋 is 261 
stochastically larger than 𝑌𝑌. For the results below, 𝜃𝜃 values between 0 and 0.2 (and 262 
similarly between 0.8 and 1) are considered strong evidence that the two 263 
distributions are substantially different. Intermediate 𝜃𝜃 values between 0.2 to 0.4 (or 264 
0.6 to 0.8) are assumed to provide weak evidence of a difference between the 265 
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distributions. Values of 𝜃𝜃 close to 0.5 (between 0.4 and 0.6) indicate that there is no 266 
evidence that the two distributions being compared are dissimilar. 267 
RESULTS 268 
The results for the normal burden setting and high burden setting are summarized 269 
below. More detailed comparisons of the interventions combinations for all outcome 270 
measures using the generalized Mann-Whitney statistic are provided in the 271 
supplementary material. 272 
The results for the AC, 𝐼𝐼𝑥𝑥𝑥𝑥 and 𝐼𝐼𝑥𝑥  outcomes were similar for both the normal and high 273 
burden settings, and discussed together here. Results for the AR, 𝐶𝐶𝑥𝑥𝑥𝑥  and 𝐶𝐶𝑥𝑥  274 
outcomes are discussed separately for the normal burden setting and high burden 275 
setting. 276 
The most important intervention for the AC outcome was the COA intervention which 277 
eliminates the possibility of colonized patients being admitted. As such, the COA 278 
intervention (and any other intervention combinations which include COA) greatly 279 
outperforms interventions of any size which do not include the COA intervention in 280 
both settings. Any intervention combination which includes the COA intervention 281 
achieved 0 AC, whereas intervention combinations without the COA intervention 282 
produced AC distributions with 95% intervals that do not include 0. 283 
The performance of the interventions on the 𝐼𝐼𝑥𝑥outcome was very similar to that for 284 
the 𝐼𝐼𝑥𝑥𝑥𝑥  since the only transition to Id  is through 𝐼𝐼𝑥𝑥𝑥𝑥, i.e. eliminating the 𝐼𝐼𝑥𝑥𝑥𝑥  would also 285 
eliminate the 𝐼𝐼𝑥𝑥 population. As such, only the results for the 𝐼𝐼𝑥𝑥𝑥𝑥  results are discussed 286 
for brevity as identical inferences apply to the 𝐼𝐼𝑥𝑥𝑥𝑥  outcome. The SENS intervention 287 
was the most important intervention for the 𝐼𝐼𝑥𝑥𝑥𝑥 outcome as having perfect sensitivity 288 
14 
would allow detection of all colonized patients prior to infection developing. As such, 289 
the best performing intervention of any size will include the SENS intervention. 290 
However, it should also be noted that the 𝐼𝐼𝑥𝑥𝑥𝑥  outcome is generally small for the 291 
normal burden setting with even the baseline 𝐼𝐼𝑥𝑥𝑥𝑥having a 95% interval of [0, 2] 292 
(Table 2). 293 
In contrast with the normal burden setting, the SENS intervention (or any 294 
combination which includes the SENS intervention) was substantially more 295 
favourable in the high burden setting (Table 5). The SENS intervention substantially 296 
outperformed all intervention combinations which excluded the SENS intervention 297 
here. 298 
Normal burden setting 299 
Table 2 provides the numerical summary of the six outcome measures under the 300 
baseline and the various combinations of the five interventions investigated. The 301 
baseline scenario refers to the case without any interventions. 302 
There were great improvements in reducing the AR outcome when increasing the 303 
number of interventions by up to three with the optimal triplet being {COA, ENV, CP} 304 
(2.66 (2.20, 3.31)  × 10−3). This triplet outperformed the best single intervention (CP 305 
with AR of 4.32 (3.69, 5.05)  × 10−3) and intervention pair ({COA, CP} with AR of 306 3.35 (2.88, 4.01)  × 10−3). The addition of one extra intervention (either DECOL or 307 
SENS) did not seem to have a drastic effect on the AR distribution 308 
(2.50 (2.13, 3.02)  × 10−3 and 2.53 (2.19, 2.92) × 10−3 respectively). However, there is 309 
a benefit in implementing all five interventions (AR =  2.39 (2.11, 2.71)  × 10−3) 310 
compared with just the best three interventions. 311 
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For the 𝐶𝐶𝑥𝑥𝑥𝑥  outcome, the two best performing pairs ({ENV, CP} and {COA, CP} with 312 
𝐶𝐶𝑥𝑥𝑥𝑥 of 17.59 (10, 27) and 17.60 (9, 28), respectively) performed slightly better 313 
compared with the best single intervention (CP with 𝐶𝐶𝑥𝑥𝑥𝑥of 20.78 (12, 31)). A similar 314 
performance gain was noted when comparing the best intervention triplet ({COA, 315 
ENV, CP} with 𝐶𝐶𝑥𝑥𝑥𝑥  =14.29 (6, 24)) to both the best performing pairs. There does not 316 
appear to be substantial changes in the 𝐶𝐶𝑥𝑥𝑥𝑥 difference when comparing across the 317 
best performing triplet, quartets ({COA, ENV, CP, SENS} and {COA, ENV, CP, 318 
DECOL} with 𝐶𝐶𝑥𝑥𝑥𝑥of 13.65 (6, 23) and 13.94 (6, 23) respectively) and the combination 319 
of all interventions (13.44 (6, 22)), indicating that there is little gain from considering 320 
anything beyond the best performing triplet in reducing the distributional outcome of 321 
𝐶𝐶𝑥𝑥𝑥𝑥  for this scenario.  322 
Comparing across different intervention sizes for the 𝐶𝐶𝑥𝑥  outcome, there are notable 323 
reductions in support for considering additional numbers of interventions up to the 324 
best performing intervention triplet ({COA, ENV, CP} with 𝐶𝐶𝑥𝑥  of 13.96 (6, 24)). The 325 
best performing single intervention for the 𝐶𝐶𝑥𝑥  outcome was COA (24.22 (14, 36)) and 326 
the best performing intervention pair was {COA, CP} (17.21 (9.5, 27)). There are no 327 
discernible difference in the 𝐶𝐶𝑥𝑥  outcome distributions in implementing all five 328 
interventions (𝐶𝐶𝑥𝑥= 13.43 (6, 22)) or either of the two best performing quartets 329 
identified ({COA, ENV, CP, DECOL} and {COA, ENV, CP, SENS} with 𝐶𝐶𝑥𝑥  of 13.32 330 
(6, 22) and 13.95 (6, 23) respectively) compared with having just the best performing 331 
intervention triplet (with 𝜃𝜃 estimates ranging from 0.46 to 0.50). 332 
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High burden setting 333 
The mean and 95% intervals for the six outcome measures across the different 334 
intervention combinations considered are listed in Table 4. Compared with the 335 
baseline scenario in the normal burden setting (Table 2), we see notable increases 336 
in the average AR, 𝐶𝐶𝑥𝑥𝑥𝑥, 𝐶𝐶𝑥𝑥, 𝐼𝐼𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥outcomes but a slight reduction in the AC 337 
outcome likely due to the decreased number of admissions overall as colonized and 338 
infected patients stay in the ward longer.  339 
For the AR outcome in the high burden setting, there is evidence to consider 340 
implementing the maximum number of interventions possible (subject to resource 341 
constraint) beginning with the CP intervention (12.44 (10.14, 14.83)  × 10−3), followed 342 
by the SENS intervention ({CP, SENS} with AR of 9.50 (8.35, 10.79)  × 10−3), either 343 
the COA or ENV intervention ({COA, CP, SENS} with AR of 7.88 (6.77, 9.14) × 10−3 344 
or {ENV, CP, SENS} with AR 7.97 (6.71, 9.24)  × 10−3) or both ({COA, ENV, CP, 345 
SENS} with AR 6.25 (5.10, 7.53)  × 10−3), up to all five interventions 346 
(5.55 (4.73, 6.46) × 10−3). The reduction in the AR distribution when moving from the 347 
best performing quartet to all intervention was not as drastic as the other increases 348 
in intervention sizes. 349 
Only small gains were obtained from increasing the size of the intervention 350 
combinations sequentially for the 𝐶𝐶𝑥𝑥𝑥𝑥 outcome. More notable reductions were 351 
obtained by moving from the best performing single intervention (CP with 𝐶𝐶𝑥𝑥𝑥𝑥 of 352 
45.46 (30, 61)) to at least one of the best performing triplets ({ENV, CP, SENS}, 353 
{COA, ENV, CP} or {COA, CP, SENS} with 𝐶𝐶𝑥𝑥𝑥𝑥’s of 36.57 (23, 50), 37.24 (22, 53) 354 
and 39.21 (26, 55) respectively), and similarly from one of the best performing 355 
intervention pairs ({ENV, CP}, {CP, SENS} or {COA, CP} with 𝐶𝐶𝑥𝑥𝑥𝑥’s of 40.95 (28, 356 
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55.5), 42.70 (29.5, 58) and 43.56 (28, 60) respectively) to either the {COA, ENV, CP, 357 
SENS} quartet (32.02 (19, 46)) or all five interventions (29.95 (17, 45)). 358 
For the 𝐶𝐶𝑥𝑥  outcome measure, the results obtained suggest it would be beneficial to 359 
consider up to the best performing triplet of interventions ({COA, ENV, CP} with 𝐶𝐶𝑥𝑥  360 
33.85 (20, 49)) subject to resource constraints. The best performing single 361 
interventions were COA (53.96 (39, 72.5)) and CP (55.58 (39, 74)), and the best 362 
performing intervention pair was {COA, CP} (39.72 (26, 55)). There was only a slight 363 
gain in moving from the best performing triplet to the combination of all interventions 364 
(29.95 (17, 45)). The two best performing intervention quartets ({COA, ENV, CP, 365 
SENS} and {COA, ENV, CP, DECOL}) (with 𝐶𝐶𝑥𝑥’s of 32.02 (19, 46) and 32.80 (19, 366 
49) respectively) did not yield 𝐶𝐶𝑥𝑥distributions substantially different from the best 367 
performing triplet. 368 
DISCUSSION 369 
The results obtained from the proposed stochastic model showed that there are 370 
differences in the optimal set of interventions depending on the outcome measure of 371 
interest as well as the burden setting of the pathogen (as summarized in Table 6). 372 
For the AC outcome, 𝐼𝐼𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥  outcome measures where one of the interventions 373 
considered eradicated the respective outcome measure (COA for the AC outcome 374 
and SENS for both 𝐼𝐼𝑥𝑥𝑥𝑥 and 𝐼𝐼𝑥𝑥), only that particular intervention was required. This 375 
finding, particular for the 𝐼𝐼𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥  outcome measures, may not be terribly realistic 376 
given that there is always some amount of delay between sample collection and the 377 
corresponding action based on the screening results. However, the 𝜃𝜃 performance 378 
measure still showed that in the normal burden setting, eradication of 𝐼𝐼𝑥𝑥𝑥𝑥 and 𝐼𝐼𝑥𝑥  was 379 
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only a slight improvement compared with the other intervention combinations and the 380 
baseline on the account of the already low baseline 𝐼𝐼𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥 prevalence. This is not 381 
the case in the high burden setting where eradication of the 𝐼𝐼𝑥𝑥𝑥𝑥  and 𝐼𝐼𝑥𝑥  outcomes with 382 
the SENS intervention was drastically different from the other intervention 383 
combinations which exclude SENS and the baseline scenario. The addition of the 384 
aforementioned small delay would have affected all scenarios considered equally 385 
and would unlikely have changed the finding in the normal burden setting. It is also 386 
unlikely to change the findings in the high burden setting unless the delay was 387 
substantive (of the order of days). 388 
The model presented used parameter estimates combined from multiple sources. 389 
While it would be ideal if the model parameters were all obtained from one source, 390 
this is frequently not the case in such modelling studies where the hypothetical 391 
investigations considered typically require some form of data collation from multiple 392 
sources in order to fully parametrize the model [5, 6, 7, 8, 9, 10]. It could also be 393 
argued that this provides such modelling studies with a level of flexibility that could 394 
not be obtained from clinical intervention studies. The lack of additional individual 395 
patient data for this study also precluded demonstration of the full utility of the 396 
individual-based patient transition component in the model. For this application, only 397 
the patient transition from 𝐼𝐼𝑥𝑥  to 𝐶𝐶𝑥𝑥  was based on their individual infection times (see 398 
expression for 𝑟𝑟𝐶𝐶). However, the model can readily include individual-specific 399 
covariates into other transition probabilities in the model as well. 400 
There are a number of extensions to the stochastic model proposed here that were 401 
not considered. Most of these extensions also involve additional data structures that 402 
are not readily available. 403 
19 
One such extension is to generalize the force of infection term such that the 404 
colonization threshold is no longer constant [1]. Under the current model formulation, 405 
the probability of a patient being colonized is only a function of the current force of 406 
infection. However, the generalization proposed in Streftaris and Gibson [1] allows 407 
for this transition to also depend on the accumulation of the force of infection terms 408 
from a patient’s admission date to their colonization date. This quantity is known as 409 
the colonization threshold and requires prior knowledge or imputation of the 410 
colonization date in order to compute it. This extension is another approach to 411 
incorporate patient heterogeneity into the model, specifically related to patient 412 
susceptibility.  413 
Another potential extension is to extend the one ward model to a multi-ward model 414 
using one of the meta-population models [31, 32] such as the multi-patch models 415 
(where each patch represents a ward) or more generally, temporal network models 416 
taking into account the fact that the edges between nodes change quite frequently 417 
with staff shift changes, and patient admissions and discharges, making the temporal 418 
element of the network more important [33, 34]. The high-frequency contact data 419 
required for such models have only recently started to be collected [35] and could 420 
prove to be a promising research avenue in providing a realistic, detailed 421 
representation of hospital pathogen transmission in a ward. 422 
The inclusion of explicit representations of HCWs’ roles in the pathogen transmission 423 
could be considered in extensions of the model presented here. While having explicit 424 
representation of HCWs allows for more realistic investigation of HCW-related 425 
interventions, this extension requires either incorporation of additional model 426 
assumptions on the HCWs’ behaviours, or substantial additional data collection as 427 
HCWs are known to be highly heterogeneous population with different HCW 428 
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categories (e.g., nurses, physicians, technicians) having differing patient contact 429 
rates, compliance levels to infection control and prevention practices, and work 430 
schedules [15,16,17,18,19]. Also, due to the low carriage rates among HCW 431 
reported [11], frequent screening of HCWs would be required in order to accurately 432 
quantify the temporary contamination status of HCWs, which is associated with high 433 
cost and staff time. It is also likely that this extension would require the 434 
aforementioned multi-ward extension to realistically capture the impact of HCWs in 435 
MRSA transmission as HCWs tend to work across multiple wards.  436 
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SUPPLEMENTARY MATERIAL 437 
Supplementary material is available on the Cambridge Journals online website. 438 
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Table 1: Parameter values for the stochastic model describing MDRO transmission in a hospital ward 547 
Symbol  Definition  Value Source* 
𝑀𝑀 maximum ward capacity (𝑀𝑀 =  𝑆𝑆(𝑡𝑡)  +  𝐶𝐶(𝑡𝑡)  +  𝐼𝐼(𝑡𝑡)  +  𝐴𝐴(𝑡𝑡))  20 data  
𝜆𝜆 daily admission rate to ward  5 data  
𝜗𝜗 probability of being susceptible on admission  0.95 [17] 
𝑝𝑝𝐿𝐿 probability of leaving the ward as a susceptible patient  0.1155 [1] 
𝑞𝑞𝐿𝐿 probability of leaving the ward as a colonized patient  0.053 [1]  
𝑞𝑞𝐼𝐼 probability of a colonized patient developing an infection  0.047 [17] 
𝑞𝑞𝐶𝐶 probability of a colonized patient remaining colonized  1 −  𝑞𝑞𝐿𝐿 −  𝑞𝑞𝐼𝐼 ≈  0.900  
𝜓𝜓 parameter in functional form for probability of recovering from infection to 
colonized state 𝑟𝑟𝐶𝐶  
0.020 [1] 
𝜌𝜌 screening test sensitivity  0.8 assumption 
𝛽𝛽0 intercept term associated with 𝑓𝑓𝐸𝐸 (× 105) 190 unpublished observations 
𝛽𝛽1 undetected colonized patients related parameter in expression for 𝑓𝑓𝐸𝐸 (× 105) 660 × 2𝜔𝜔 + 1 unpublished observations 
𝛽𝛽2 detected colonized patients related parameter in expression for 𝑓𝑓𝐸𝐸 (× 105) 48 × 2𝜔𝜔 + 1 unpublished observations 
𝛽𝛽3 undetected infected patients related parameter in expression for 𝑓𝑓𝐸𝐸  𝜔𝜔 𝛽𝛽1 unpublished observations 
𝛽𝛽4 detected infected patients related parameter in expression for 𝑓𝑓𝐸𝐸  𝜔𝜔 𝛽𝛽2 unpublished observations 
𝛽𝛽5 environmental contamination related parameter inexpression for 𝑓𝑓𝐸𝐸  (×105) 2.7 unpublished observations 
𝜔𝜔 ratio difference between effects of colonized and infected patients in 𝑓𝑓𝐸𝐸  1 assumption 
𝑎𝑎1 AR(1) coefficient  1.40 (0.08) data 
𝑎𝑎2 AR(2) coefficient  -0.48 (0.08) data  
𝑏𝑏1 MA(1) coefficient  0.34 (0.09) data  
𝑏𝑏0 MA(2) coefficient  0.30 (0.06) data  
𝛼𝛼1 time series time-constant mean parameter  60 (5) data  
𝛼𝛼2 time series coefficient for 𝐶𝐶𝑥𝑥𝑥𝑥 at previous time period  -0.07 (0.4) data 
𝛼𝛼3 time series coefficient for 𝐼𝐼𝑥𝑥𝑥𝑥 at previous time period  0.06(0.3) data 
27 
𝛼𝛼4 time series coefficient for intervention -0.10 (3.7) data  
𝜎𝜎2 white noise variance  24.5 data 
* Unpublished observations are estimates obtained from fitting a non-homogeneous Poisson process to the data. More details 548 
provided in the supplementary material. 549 
AR, autoregressive; MA, moving average. 550 
  551 
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Table 2: Numerical summaries of output measures for normal burden setting. 552 
  AR ×  103   AC   𝐶𝐶𝑥𝑥𝑥𝑥  𝐶𝐶𝑥𝑥  𝐼𝐼𝑥𝑥𝑥𝑥 𝐼𝐼𝑥𝑥 
baseline  6.14 (5.15, 7.17) 20.91 (12.50, 30) 28.53 (17, 41.5) 48.24 (34, 63) 0.56 (0, 2) 0.56 (0, 2) 
COA  4.82 (4.04, 5.71) 0 24.79 (14, 37) 24.22 (14, 36) 0.27 (0, 2) 0.27 (0, 2) 
ENV  5.14 (4.30, 6.22) 21.22 (13, 30) 24.10 (13, 35) 44.26 (31, 58) 0.51 (0, 2) 0.50 (0, 2) 
CP  4.32 (3.69, 5.05) 21.52 (13, 30) 20.78 (12, 31) 41.29 (30, 55) 0.47 (0, 2) 0.47 (0, 2) 
SENS  5.69 (4.98, 6.43) 22.07 (14, 31) 27.13 (17, 40) 49.20 (36, 64) 0 0 
DECOL  5.57 (4.79, 6.61) 23.57 (15, 34) 27.57 (16, 41) 49.91 (36, 66) 0.59 (0, 2) 0.58 (0, 2) 
COA, ENV  3.84 (3.13, 4.76) 0 19.94 (10, 32) 19.44 (10, 30) 0.23 (0, 1) 0.23 (0, 1) 
COA, CP  3.35 (2.88, 4.01) 0 17.59 (10, 27) 17.21 (9.5, 27) 0.18 (0, 1) 0.18 (0, 1) 
COA, SENS  4.58 (3.95, 5.35) 0 23.98 (13, 37) 23.98 (13, 37) 0 0 
COA, DECOL  4.50 (3.88, 5.32) 0 24.26 (13.5, 36) 23.70 (13, 35) 0.27 (0, 2) 0.27 (0, 2) 
ENV, CP  3.64 (3.00, 4.37) 21.76 (13.5, 31) 17.60 (9, 28) 38.37 (26, 51) 0.47 (0, 2) 0.46 (0, 2) 
ENV, SENS  4.77 (4.08, 5.52) 22.43 (14, 31) 23.33 (13, 35) 45.76 (32, 61) 0 0 
ENV, DECOL  4.65 (3.84, 5.55) 23.74 (15, 33) 23.37 (13, 35) 45.98 (32, 61) 0.55 (0, 2) 0.55 (0, 2) 
CP, SENS  4.05 (3.56, 4.57) 22.80 (14, 32) 19.83 (11, 30) 42.63 (30, 57) 0 0 
CP, DECOL  3.98 (3.42, 4.67) 23.97 (14.5, 33.5) 20.37 (11, 31) 43.25 (30, 58) 0.58 (0, 2) 0.58 (0, 2) 
29 
SENS, DECOL  5.12 (4.55, 5.72) 24.77 (16, 35) 26.34 (16, 38) 51.11 (36, 66) 0 0 
COA, ENV, CP  2.66 (2.20, 3.31) 0 14.29 (6, 24) 13.96 (6, 24) 0.15 (0, 1) 0.16 (0, 1) 
COA, ENV, 
SENS  
3.59 (3.04, 4.25) 0 18.91 (10, 30) 18.91 (10, 30) 0 0 
COA, ENV, 
DECOL  
3.54 (2.98, 4.35) 0 19.02 (10, 29) 18.57 (10, 28) 0.20 (0, 1) 0.20 (0, 1) 
COA, CP, SENS  3.22 (2.82, 3.67) 0 17.47 (9, 28) 17.48 (9, 28) 0 0 
COA, CP, 
DECOL  
3.18 (2.77, 3.79) 0 17.33 (8, 28) 16.90 (8, 27) 0.19 (0, 1) 0.19 (0, 1) 
COA, SENS, 
DECOL  
4.24 (3.81, 4.71) 0 23.12 (13, 34) 23.14 (13, 34) 0 0 
ENV, CP, SENS  3.38 (2.88, 3.92) 22.62 (14, 31.50) 16.82 (8, 27) 39.45 (26.50, 53) 0 0 
ENV, CP, 
DECOL  
3.30 (2.80, 3.95) 23.76 (15, 33) 16.96 (8, 27) 39.72 (27, 54) 0.48 (0, 2) 0.48 (0, 2) 
ENV, SENS, 
DECOL  
4.21 (3.65, 4.79) 24.70 (15, 35) 21.71 (12, 33) 46.38 (31, 63.5) 0 0 
CP, SENS, 3.67 (3.26, 4.08) 24.58 (16, 34) 19.12 (10, 29) 43.70 (31, 59) 0 0 
30 
DECOL  
COA, ENV, CP, 
SENS  
2.53 (2.19, 2.92) 0 13.94 (6, 23) 13.95 (6, 23) 0 0 
COA, ENV, CP, 
DECOL  
2.50 (2.13, 3.02) 0 13.65 (6, 23) 13.32 (6, 22) 0.15 (0, 1) 0.14 (0, 1) 
COA, ENV, 
SENS, DECOL  
3.34 (2.91, 3.81) 0 18.57 (9, 29.5) 18.57 (9, 29.5) 0 0 
COA, CP, SENS, 
DECOL  
3.04 (2.73, 3.38) 0 16.88 (9, 27) 16.87 (9, 27) 0 0 
ENV, CP, SENS, 
DECOL  
3.02 (2.66, 3.41) 24.96 (16, 35.5) 15.88 (9, 25) 40.84 (28, 56) 0 0 
all  2.39 (2.11, 2.71) 0 13.44 (6, 22) 13.43 (6, 22) 0 0 
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Table 3: Summary of intervention combination comparisons for the normal burden 553 
setting. 554 
outcome  comparison   𝜃𝜃� (95\% CI)  
AR  CP v baseline  0.00 (0.00, 0.00) 
  {COA, CP} v CP  0.02 (0.01, 0.03) 
  {COA, ENV, CP} v {COA, CP}  0.04 (0.04, 0.06) 
  {COA, ENV, CP, DECOL} v {COA, ENV, 
CP}  
0.33 (0.30, 0.35) 
  {COA, ENV, CP, SENS} v {COA, ENV, 
CP}  
0.38 (0.35, 0.40) 
  all v {COA, ENV, CP}  0.20 (0.18, 0.22) 
  all v {COA, ENV, CP, DECOL}  0.35 (0.33, 0.38) 
  all v {COA, ENV, CP, SENS}  0.28 (0.26, 0.30) 
𝐶𝐶𝑥𝑥𝑥𝑥  CP v baseline  0.17 (0.15, 0.19) 
  {COA, CP} v CP  0.32 (0.30, 0.35) 
  {ENV, CP} v CP  0.33 (0.30, 0.35) 
  {COA, ENV, CP} v {COA, CP}  0.30 (0.28, 0.33) 
  {COA, ENV, CP} v {ENV, CP}  0.31 (0.29, 0.33) 
  {COA, ENV, CP, DECOL} v {COA, ENV, 
CP}  
0.46 (0.44, 0.49) 
  {COA, ENV, CP, SENS} v {COA, ENV, 
CP}  
0.48 (0.46, 0.51) 
  all v {COA, ENV, CP}  0.45 (0.42, 0.47) 
  all v {COA, ENV, CP, DECOL}  0.49 (0.46, 0.51) 
  all v {COA, ENV, CP, SENS}  0.47 (0.44, 0.49) 
𝐶𝐶𝑥𝑥  COA v baseline  0.01 (0.00, 0.01) 
32 
  {COA, CP} v COA  0.17 (0.15, 0.19) 
  {COA, ENV, CP} v {COA, CP}  0.31 (0.28, 0.33) 
  {COA, ENV, CP, DECOL} v {COA, ENV, 
CP}  
0.46 (0.44, 0.49) 
  {COA, ENV, CP, SENS} v {COA, ENV, 
CP}  
0.50 (0.48, 0.53) 
  all v {COA, ENV, CP}  0.47 (0.44, 0.49) 
  all v {COA, ENV, CP, DECOL}  0.51 (0.48, 0.53) 
  all v {COA, ENV, CP, SENS}  0.47 (0.44, 0.49) 
 555 
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Table 4: Numerical summaries of output measures for high burden setting. 556 
  AR ×  103  AC  𝐶𝐶𝑥𝑥𝑥𝑥 𝐶𝐶𝑥𝑥 𝐼𝐼𝑥𝑥𝑥𝑥 𝐼𝐼𝑥𝑥 
baseline  18.63 (15.63, 21.56) 13.83 (6, 23) 60.73 (45, 78) 68.07 (49, 88) 4.20 (1, 8) 4.20 (1, 8) 
COA  16.22 (12.55, 19.76) 0 59.22 (43.5, 78) 53.96 (39, 72.5) 3.41 (0, 8) 3.41 (0, 8) 
ENV  16.42 (13.16, 19.59) 14.32 (6, 24) 55.39 (39.5, 72) 63.52 (47, 82) 3.97 (1, 8) 3.97 (1, 8) 
CP  12.44 (10.14, 14.83) 15.57 (7, 25) 45.46 (30, 61) 55.58 (39, 74) 3.52 (0, 7) 3.52 (0, 7) 
SENS  14.00 (12.17, 15.92) 20.20 (13, 29) 58.57 (42, 75) 78.79 (61, 98) 0 0 
DECOL  17.61 (14.26, 20.91) 16.44 (7, 27) 63.51 (45, 82) 72.99 (52, 96) 4.52 (1, 9) 4.51 (1, 9) 
COA, ENV  13.70 (9.91, 17.42) 0 52.63 (34, 70.5) 47.98 (31.5, 65) 3.04 (0, 7) 3.05 (0, 7) 
COA, CP  10.33 (7.94, 13.11) 0 43.56 (28, 60) 39.72 (26, 55) 2.45 (0, 6) 2.44 (0, 6) 
COA, SENS  11.85 (10.13, 13.83) 0 54.80 (37, 73.5) 54.81 (37, 73) 0 0 
COA, DECOL  14.85 (11.32, 18.85) 0 61.01 (43, 80.5) 55.65 (38, 74) 3.33 (0, 7.5) 3.33 (0, 8) 
ENV, CP  10.82 (8.63, 13.19) 16.12 (8, 25) 40.95 (28, 55.5) 52.04 (37, 68) 3.26 (0, 7) 3.26 (0, 7) 
ENV, SENS  11.90 (10.05, 13.81) 20.70 (12, 30) 51.55 (36, 69) 72.25 (54, 93) 0 0 
ENV, DECOL  15.33 (11.98, 18.64) 17.20 (8, 27) 57.71 (41, 77) 68.36 (49.5, 88) 4.22 (1, 8) 4.23 (1, 8) 
CP, SENS  9.50 (8.35, 10.79) 21.33 (13, 30) 42.70 (29.5, 58) 64.05 (48, 81) 0 0 
CP, DECOL  11.66 (9.34, 14.13) 18.35 (9, 28) 46.70 (32.5, 63) 59.37 (43, 79) 3.65 (1, 8) 3.66 (1, 8) 
34 
SENS, DECOL  12.22 (10.71, 13.81) 24.48 (16, 34) 58.48 (41.5, 79) 82.98 (63, 105) 0 0 
COA, ENV, CP  8.51 (6.09, 11.46) 0 37.24 (22, 53) 33.85 (20, 49) 2.23 (0, 6) 2.23 (0, 6) 
COA, ENV, 
SENS  
9.56 (7.72, 11.62) 0 45.56 (27.5, 63) 45.53 (27.5, 63) 0 0 
COA, ENV, 
DECOL  
12.44 (8.80, 16.63) 0 52.54 (35, 72) 47.73 (32, 66.5) 3.10 (0, 7) 3.08 (0, 7) 
COA, CP, 
SENS  
7.88 (6.77, 9.14) 0 39.21 (26, 55) 39.22 (26, 55) 0 0 
COA, CP, 
DECOL  
9.55 (7.30, 12.11) 0 43.19 (28, 59) 39.34 (26, 54.5) 2.47 (0, 6) 2.48 (0, 6) 
COA, SENS, 
DECOL  
10.33 (8.89, 11.77) 0 52.55 (34, 71) 52.52 (34, 71.5) 0 0 
ENV, CP, 
SENS  
7.97 (6.71, 9.24) 21.55 (14, 30) 36.57 (23, 50) 58.10 (42, 74) 0 0 
ENV, CP, 
DECOL  
10.11 (7.72, 12.68) 18.54 (9, 29) 41.32 (27, 57) 54.60 (39, 72.5) 3.43 (0, 7) 3.42 (0, 7) 
ENV, SENS, 10.14 (8.65, 11.60) 24.76 (15, 35) 49.23 (33, 66.5) 73.98 (53, 94) 0 0 
35 
DECOL  
CP, SENS, 
DECOL  
8.38 (7.40, 9.38) 24.59 (15, 34) 41.43 (28, 56) 65.97 (49, 84) 0 0 
COA, ENV, CP, 
SENS  
6.26 (5.10, 7.53) 0 32.02 (19, 46) 32.02 (19, 46) 0 0 
COA, ENV, CP, 
DECOL  
7.71 (5.51, 10.51) 0 36.02 (20, 53) 32.80 (19, 49) 2.08 (0, 5.5) 2.08 (0, 5.5) 
COA, ENV, 
SENS, DECOL  
8.18 (6.90, 9.61) 0 42.35 (25.5, 60.5) 42.37 (26, 60.5) 0 0 
COA, CP, 
SENS, DECOL  
7.03 (6.26, 7.93) 0 37.21 (24, 53) 37.22 (24, 53) 0 0 
ENV, CP, 
SENS, DECOL  
6.92 (5.96, 7.96) 24.59 (15, 35) 34.80 (22, 50) 59.40 (41, 78.5) 0 0 
all  5.55 (4.73, 6.46) 0 29.95 (17, 45) 29.95 (17, 45) 0 0 
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Table 5: Summary of intervention combination comparisons for the normal burden 557 
setting. 558 
outcome  comparison  𝜃𝜃� (95\% CI) 
AR  CP v baseline  0.00 (0.00, 0.00) 
  {CP, SENS} v CP  0.01 (0.01, 0.02) 
  {COA, CP, SENS} v {CP, SENS}  0.03 (0.02, 0.04) 
  {ENV, CP, SENS} v {CP, SENS}  0.04 (0.04, 0.05) 
  {COA, ENV, CP, SENS} v {COA, CP, 
SENS}  
0.03 (0.02, 0.04) 
  {COA, ENV, CP, SENS} v {ENV, CP, 
SENS}  
0.03 (0.02, 0.04) 
  all v {COA, ENV, CP, SENS}  0.16 (0.15, 0.18) 
𝐶𝐶𝑥𝑥𝑥𝑥  CP v baseline  0.09 (0.08, 0.10) 
  {ENV, CP} v CP  0.33 (0.31, 0.36) 
  {CP, SENS} v CP  0.39 (0.37, 0.42) 
  {COA, CP} v CP  0.43 (0.40, 0.45) 
  {ENV, CP, SENS} v CP  0.19 (0.18, 0.21) 
  {COA, ENV, CP} v CP  0.22 (0.20, 0.24) 
  {COA, CP, SENS} v CP  0.27 (0.25, 0.30) 
  {ENV, CP, SENS} v {ENV, CP}  0.33 (0.31, 0.36) 
  {COA, ENV, CP} v {ENV, CP}  0.36 (0.34, 0.38) 
  {COA, CP, SENS} v {ENV, CP}  0.43 (0.40, 0.45) 
  {ENV, CP, SENS} v {CP, SENS}  0.27 (0.25, 0.30) 
  {COA, ENV, CP} v {CP, SENS}  0.30 (0.28, 0.33) 
  {COA, CP, SENS} v {CP, SENS}  0.37 (0.34, 0.39) 
  {ENV, CP, SENS} v {COA, CP}  0.25 (0.23, 0.27) 
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  {COA, ENV, CP} v {COA, CP}  0.28 (0.26, 0.30) 
  {COA, CP, SENS} v {COA, CP}  0.34 (0.32, 0.36) 
  {COA, ENV, CP, SENS} v {ENV, CP}  0.19 (0.17, 0.21) 
  {COA, ENV, CP, SENS} v {CP, SENS}  0.15 (0.13, 0.17) 
  {COA, ENV, CP, SENS} v {COA, CP}  0.14 (0.12, 0.16) 
  {COA, ENV, CP, SENS} v {ENV, CP, 
SENS}  
0.33 (0.30, 0.35) 
  {COA, ENV, CP, SENS} v {COA, ENV, 
CP}  
0.32 (0.29, 0.34) 
  {COA, ENV, CP, SENS} v {COA, CP, 
SENS}  
0.25 (0.23, 0.27) 
  all v {ENV, CP}  0.13 (0.12, 0.15) 
  all v {CP, SENS}  0.10 (0.09, 0.12) 
  all v {COA, CP}  0.10 (0.08, 0.11) 
  all v {ENV, CP, SENS}  0.25 (0.23, 0.27) 
  all v {COA, ENV, CP}  0.24 (0.22, 0.26) 
  all v {COA, CP, SENS}  0.18 (0.16, 0.20) 
  all v {COA, ENV, CP, SENS}  0.42 (0.39, 0.44) 
𝐶𝐶𝑥𝑥  COA v baseline  0.14 (0.12, 0.15) 
  {COA, CP} v COA  0.10 (0.09, 0.11) 
  {COA, ENV, CP} v COA  0.03 (0.03, 0.04) 
  {COA, ENV, CP} v {COA, CP}  0.28 (0.26, 0.30) 
  {COA, ENV, CP, SENS} v {COA, CP}  0.23 (0.21, 0.25) 
  {COA, ENV, CP, DECOL} v {COA, CP}  0.25 (0.23, 0.27) 
  {COA, ENV, CP, SENS} v {COA, ENV, 
CP}  
0.43 (0.41, 0.46) 
  {COA, ENV, CP, DECOL} v {COA, ENV, 0.46 (0.43, 0.48) 
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CP}  
  all v {COA, CP}  0.16 (0.15, 0.18) 
  all v {COA, ENV, CP}  0.35 (0.32, 0.37) 
  all v {COA, ENV, CP, SENS}  0.42 (0.39, 0.44) 
  all v {COA, ENV, CP, DECOL}  0.39 (0.37, 0.41) 
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Table 6: Overall order of importance for the five interventions considered under the 560 
normal and high burden setting. // denotes exchangeability in the order of the 561 
interventions and || denotes the optimal sized interventions i.e. addition of 562 
interventions to the right of the || symbol would not affect the associated outcome 563 
measure. 564 
Outcome 
measure  
 normal burden setting   high burden setting  
AR  CP, COA, ENV, DECOL // SENS CP, SENS, COA // ENV, DECOL 
AC  COA || . COA || . 
C_{xd}  CP, COA//ENV || DECOL // SENS CP, ENV // COA // SENS || DECOL 
C_d  COA, CP, ENV || DECOL // SENS COA // CP, ENV || SENS // DECOL 
I_{xd}  SENS || . SENS || . 
I_d  SENS || . SENS || . 
 565 
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Legends for figures 566 
Figure 1: Compartmental diagram for the MRSA transmission model incorporating 567 
environmental contamination. The solid black lines represent patient transitions 568 
between the different states as well as admissions and discharges (only for the 569 
𝑆𝑆(𝑡𝑡) and 𝐶𝐶𝑥𝑥𝑥𝑥(𝑡𝑡) compartments). The red dashed lines denote the contribution from 570 
the various compartments to the colonization process while the black dashed lines 571 
show the compartments contributing to the evolution of the 𝐸𝐸(𝑡𝑡) compartment. 572 
 573 
Figure 2: AR outcome for normal burden (left plot) and high burden (right plot) 574 
settings. The x-axis denotes the baseline, low 𝜔𝜔 value and high 𝜔𝜔 value (moving 575 
from left to right). 576 
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